It has been estimated that 4–6% of SFT patients develop hypoglycemia due to circulating big IGF-2 [3], and the mean time elapsed from tumor detection until the onset of big IGF-2-induced hypoglycemia is reportedly 8.5 ± 1.9 months [1]. Here, IGF2 is linked to Hypoglycemia.